This study showed that continued insulin aspart treatment in T2DM patients after intensive insulin therapy relieved oxidative stress to a significant extent, and its mechanism might involve insulin, which improved mitochondrial function and suppressed cytokines to further alleviate oxidative stress [47]. The gene discussed is INS; the disease is type 2 diabetes mellitus.